NASDAQ
European Biotech Acquisition Corp. (EBAC) has a current ratio of 0.45x as of Tuesday, May 26, 2026. This represents a 75.29% decrease compared to its 12-month average of 1.81x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.